Alternatives to TeraCyte

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

AI-driven platform for protein-level disease mapping and drug discovery.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

AI-powered blood test for early cancer detection and subtyping.

Compressing biology to develop the next generation of therapies.

AI-powered insights platform for life sciences and biotech workflows.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Unleashing the power of genomics at scale for biological advances and human health.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

AI-driven digital twin of embryo development for cell-based therapies.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.

Life sciences data platform for deep-phenotype multi-omics datasets.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.